 ADMS stock is seeing huge gains this morning as it announces a planned merger with fellow biopharma company Supernus worth 400 million. The post ADMS Stock Soars 70 Thanks to Adamas Pharmaceuticals Acquisition News appeared first on InvestorPlace. 